| dc.date.accessioned | 2020-04-21T03:31:03Z | |
| dc.date.available | 2020-04-21T03:31:03Z | |
| dc.date.issued | 2020-04-17 | |
| dc.identifier.uri | https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/1129 | |
| dc.description.abstract | The information contained in this evidence table is emerging and rapidly evolving because of ongoing research and is subject to the professional judgment and interpretation of the practitioner due to the uniqueness of each medical facility’s approach to the care of patients with COVID-19 and the needs of individual patients. ASHP provides this evidence table to help practitioners better understand current approaches related to treatment and care. ASHP has made reasonable efforts to ensure the accuracy and appropriateness of the information presented. | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Antiviral Agents | en_US |
| dc.title | Assessment of Evidence for COVID-19-Related Treatments: Updated 4/17/2020 | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Candidate therapeutics RD | en_US |
| eihealth.type | Research protocol information | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.contributor.corporatename | ASHP pharmacists advancing healthcare | en_US |
